Curcumin inhibits liver cancer by regulating Bcl-9/β-catenin pathway

Minerva Gastroenterol (Torino). 2024 Mar;70(1):137-139. doi: 10.23736/S2724-5985.23.03476-9. Epub 2023 Jun 30.

Authors

Gang Wang¹, Meng Lu², Hongyan Jia³

Affiliations

¹ Third Department of General Surgery, Cangzhou Central Hospital, Cangzhou, China.
² Department of Vascular Surgery, Cangzhou Central Hospital, Cangzhou, China.
³ Department of Radiological Intervention, Cangzhou Central Hospital, Cangzhou, China - 626922636@qq.com.

PMID: 37389849
DOI: 10.23736/S2724-5985.23.03476-9

No abstract available

MeSH terms

Curcumin* / pharmacology
Curcumin* / therapeutic use
Humans
Liver Neoplasms* / drug therapy
beta Catenin / metabolism

Substances

beta Catenin
Curcumin